Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients With Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Clin. Cancer Res 2023 Jun 26;[EPub Ahead of Print], A Oaknin, B Pothuri, L Gilbert, R Sabatier, J Brown, S Ghamande, C Mathews, DM O'Malley, R Kristeleit, V Boni, A Gravina, S Banerjee, R Miller, J Pikiel, MR Mirza, N Dewal, G Antony, Y Dong, E Zografos, J Veneris, AV TinkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.